Thermo Fisher Scientific (TMO) Stock: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$654.80
2.29 (0.35%)
â˛
5d:
-2.99%
30d:
+7.6%
90d:
+26.51%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 28, 2026
24d
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TMO is fairly priced but lacks strong directional signals. At 5.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TMO is fairly priced but lacks strong directional signals. At 5.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$780.20
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$484.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $654.80, which is considered slightly high relative to its 30-day fair value range of $612.39 to $664.39. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.8) compared to its historical average (20.4). At these levels, the market is pricing in 5.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is currently testing key support at $648.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TMO scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is currently testing key support at $648.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TMO scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$612.39 -
$664.39
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
37.1%
Protect Your Profits
Holding TMO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($652.85)
- NEUTRAL: Trading at premium valuation - market expects 5.3% growth which is achievable
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$612.39 -
$664.39
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$648.29
Resistance Level
$683.63
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.77
Wall Street Target
$652.85
(-0.3%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
9.4%
Profit Margin
15.0%
Valuation Premium vs History
+5.3% premium
PE vs Historical
23.8 vs 20.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$689.50
(+5%)
2-Year Target
$726.05
(+11%)
3-Year Target
$764.53
(+17%)
3-Yr Target (if PE normalizes)
(PE: 24â20)
PE COMPRESSION
$656.16
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.8, Growth: 9.6%)
$862.97
(+32%)
Base:
(SPY PE: 20.4, Growth: 9.6%)
$740.65
(+13%)
Bear:
(PE: 17.3, Growth: 9.6%)
$629.55
(-4%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 35.40 | Current EPS (TTM): $18.43
Bull Case
$1072.88
(+64%)
Analyst growth 49.5%, PE expands to 39.0
Base Case
$975.34
(+49%)
Market implied 49.5%, PE stable at 35.4
Bear Case
$443.71
(-32%)
Severe decline -20.0%, PE contracts to 30.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 03, 2026 2:00 PM ET
Data refreshes hourly during market hours. Next update: 3:00 PM
Data refreshes hourly during market hours. Next update: 3:00 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 48 HOLD |
|
LH
Laboratory Corporation oâĻ |
STRONG BUY
20 analysts |
$345 | 67 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$353 | 36 SELL |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
